Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K992422Substantially Equivalent

Accusign Doa3,doa, Coc/thc/opi2000 Doa3; Biosign Doa3, Coc/thc/opi2000; Status Ds Coc/thc/opi2000

Princeton BioMeditech Corp., Monmouth Junction NJ / Special, Substantially Equivalent

K992422 is the FDA 510(k) clearance record for ACCUSIGN DOA3,DOA, COC/THC/OPI2000 DOA3; BIOSIGN DOA3, COC/THC/OPI2000; STATUS DS COC/THC/OPI2000, a class II device, cleared for Princeton BioMeditech Corp. on under FDA product code DJG (Enzyme Immunoassay, Opiates). FDA records list 72 510(k) clearances for Princeton BioMeditech Corp., from to . As of , FDA records show no recalls naming K992422.

Clearance record

Decision date
Received
(20 days to decision)
Product code
DJG Enzyme Immunoassay, Opiates
Regulation
21 CFR 862.3650
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Princeton BioMeditech Corp. 4242 U.S. Rt. 1, Monmouth Junction NJ
510(k) summary
Statement
Third party review
No

Clearances, product code DJG

Trailing 12 months
3 clearances under product code DJG in the twelve months to October 2026, January 2026 the highest month at 3.
Show the numbers
Monthly 510(k) clearances under FDA product code DJG, trailing twelve months
MonthClearances
November 20250
December 20250
January 20263
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260